Stage
Series C | AliveTotal Raised
$5MLast Raised
$5M | 24 yrs agoAbout Phase-1 Molecular Toxicology
Phase-1 Molecular Toxicology is a Healthcare/Medical Facilities & Services company based in Santa Fe, New Mexico. Phase-1 Molecular Toxicology's investors include Oxford Bioscience Partners, Gimv and Tullis Health Investors.
Phase-1 Molecular Toxicology Frequently Asked Questions (FAQ)
Where is Phase-1 Molecular Toxicology's headquarters?
Phase-1 Molecular Toxicology's headquarters is located at 2904 Rodeo Park Drive East, Santa Fe.
What is Phase-1 Molecular Toxicology's latest funding round?
Phase-1 Molecular Toxicology's latest funding round is Series C.
How much did Phase-1 Molecular Toxicology raise?
Phase-1 Molecular Toxicology raised a total of $5M.
Who are the investors of Phase-1 Molecular Toxicology?
Investors of Phase-1 Molecular Toxicology include Gimv, Oxford Bioscience Partners and Tullis Health Investors.